🔎 Trials Near Me

Home › Kanser sa Suso › Kansas › Overland Park

Pag-aaral pangklinika para sa Kanser sa Suso sa Overland Park, KS

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Overland Park. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • University of Kansas Hospital-Cancer Center, Fairway · 3 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07287917

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • KCCC Overland Park, Overland Park
  • Overland Park Regional Medical Center, Overland Park
Lahat ng edad · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT02302742

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Nagre-recruitPhase 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06500481

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

Nagre-recruitPhase 2
  • University of Kansas Medical Center, Fairway · 3 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06263543

Integrated Cancer Repository for Cancer Research

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Saint Luke's Cancer Instititute - South, Overland Park
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

Nagre-recruitPhase 2
  • KUCC - Indian Creek, Overland Park
  • KUCC - Overland Park, Overland Park
  • The University of Kansas Cancer Center (KUCC), Fairway · 3 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07220135

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Nagre-recruitPhase 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT03418961

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Overland Park

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.